Original
Uso de cinacalcet para el control del hiperparatiroidismo en pacientes con diferentes grados de insuficiencia renal
Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure
José M. Orellanaa,
, Rafael J. Estebana, Yina A. Castillaa, Rafael Fernández-Castillob, Gonzalo Nozal-Fernándezc, María A. Esteband, María García-Valverdea, Juan Bravoa
Autor para correspondencia
a UGC de Nefrología, Hospitales Virgen de las Nieves y Clínico San Cecilio, Granada, España
b Facultad de Ciencias de la Salud, Universidad de Granada, Granada, España
c UGC de Farmacia, Hospitales Virgen de las Nieves y Clínico San Cecilio, Granada, España
d UGC de Churriana, Distrito Sanitario de Granada, Granada, España
Leído
47473
Vecesse ha leído el artículo
4525
Total PDF
42948
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 237 | 22 | 259 |
| 2025 5 | 468 | 47 | 515 |
| 2025 4 | 459 | 36 | 495 |
| 2025 3 | 531 | 60 | 591 |
| 2025 2 | 476 | 46 | 522 |
| 2025 1 | 549 | 37 | 586 |
| 2024 12 | 421 | 40 | 461 |
| 2024 11 | 492 | 73 | 565 |
| 2024 10 | 436 | 54 | 490 |
| 2024 9 | 559 | 29 | 588 |
| 2024 8 | 601 | 89 | 690 |
| 2024 7 | 577 | 48 | 625 |
| 2024 6 | 387 | 50 | 437 |
| 2024 5 | 514 | 50 | 564 |
| 2024 4 | 886 | 60 | 946 |
| 2024 3 | 670 | 54 | 724 |
| 2024 2 | 672 | 58 | 730 |
| 2024 1 | 655 | 35 | 690 |
| 2023 12 | 462 | 44 | 506 |
| 2023 11 | 402 | 47 | 449 |
| 2023 10 | 492 | 74 | 566 |
| 2023 9 | 489 | 71 | 560 |
| 2023 8 | 517 | 51 | 568 |
| 2023 7 | 423 | 53 | 476 |
| 2023 6 | 480 | 49 | 529 |
| 2023 5 | 519 | 47 | 566 |
| 2023 4 | 371 | 36 | 407 |
| 2023 3 | 425 | 49 | 474 |
| 2023 2 | 422 | 34 | 456 |
| 2022 1 | 312 | 41 | 353 |
| 2022 12 | 325 | 44 | 369 |
| 2022 11 | 356 | 55 | 411 |
| 2022 10 | 426 | 58 | 484 |
| 2022 9 | 371 | 46 | 417 |
| 2022 8 | 334 | 64 | 398 |
| 2022 7 | 285 | 61 | 346 |
| 2022 6 | 275 | 48 | 323 |
| 2022 5 | 321 | 59 | 380 |
| 2022 4 | 263 | 59 | 322 |
| 2022 3 | 308 | 74 | 382 |
| 2022 2 | 256 | 47 | 303 |
| 2021 1 | 287 | 40 | 327 |
| 2021 12 | 222 | 60 | 282 |
| 2021 11 | 306 | 52 | 358 |
| 2021 10 | 328 | 52 | 380 |
| 2021 9 | 338 | 67 | 405 |
| 2021 8 | 288 | 41 | 329 |
| 2021 7 | 357 | 54 | 411 |
| 2021 6 | 307 | 51 | 358 |
| 2021 5 | 388 | 53 | 441 |
| 2021 4 | 958 | 93 | 1051 |
| 2021 3 | 541 | 73 | 614 |
| 2021 2 | 420 | 65 | 485 |
| 2020 1 | 389 | 42 | 431 |
| 2020 12 | 454 | 29 | 483 |
| 2020 11 | 379 | 38 | 417 |
| 2020 10 | 348 | 35 | 383 |
| 2020 9 | 402 | 41 | 443 |
| 2020 8 | 375 | 42 | 417 |
| 2020 7 | 372 | 38 | 410 |
| 2020 6 | 351 | 54 | 405 |
| 2020 5 | 334 | 59 | 393 |
| 2020 4 | 404 | 36 | 440 |
| 2020 3 | 397 | 48 | 445 |
| 2020 2 | 426 | 39 | 465 |
| 2020 1 | 479 | 60 | 539 |
| 2019 12 | 419 | 43 | 462 |
| 2019 11 | 348 | 40 | 388 |
| 2019 10 | 430 | 63 | 493 |
| 2019 9 | 489 | 44 | 533 |
| 2019 8 | 357 | 32 | 389 |
| 2019 7 | 388 | 48 | 436 |
| 2019 6 | 445 | 71 | 516 |
| 2019 5 | 439 | 49 | 488 |
| 2019 4 | 487 | 72 | 559 |
| 2019 3 | 349 | 55 | 404 |
| 2019 2 | 278 | 28 | 306 |
| 2019 1 | 332 | 36 | 368 |
| 2018 12 | 470 | 50 | 520 |
| 2018 11 | 636 | 26 | 662 |
| 2018 10 | 591 | 12 | 603 |
| 2018 9 | 488 | 10 | 498 |
| 2018 8 | 474 | 14 | 488 |
| 2018 7 | 552 | 23 | 575 |
| 2018 6 | 439 | 15 | 454 |
| 2018 5 | 406 | 9 | 415 |
| 2018 4 | 306 | 17 | 323 |
| 2018 3 | 250 | 11 | 261 |
| 2018 2 | 206 | 10 | 216 |
| 2018 1 | 210 | 8 | 218 |
| 2017 12 | 134 | 9 | 143 |
| 2017 11 | 221 | 23 | 244 |
| 2017 10 | 212 | 5 | 217 |
| 2017 9 | 161 | 16 | 177 |
| 2017 8 | 205 | 11 | 216 |
| 2017 7 | 193 | 12 | 205 |
| 2017 6 | 214 | 46 | 260 |
| 2017 5 | 216 | 14 | 230 |
| 2017 4 | 147 | 27 | 174 |
| 2017 3 | 149 | 27 | 176 |
| 2017 2 | 129 | 42 | 171 |
| 2016 1 | 135 | 17 | 152 |
| 2016 12 | 73 | 10 | 83 |
| 2016 11 | 131 | 20 | 151 |
| 2016 10 | 184 | 20 | 204 |
| 2016 9 | 233 | 24 | 257 |
| 2016 8 | 263 | 25 | 288 |
| 2016 7 | 345 | 30 | 375 |
| 2016 6 | 274 | 0 | 274 |
| 2016 5 | 409 | 0 | 409 |
| 2016 4 | 442 | 0 | 442 |
| 2016 3 | 372 | 0 | 372 |
| 2016 2 | 43 | 0 | 43 |
Mostrar todo
